BDBM454704 (S)-6-((1-amino-1-oxopropan-2- yl)amino)-2-(1-(4- (trifluoromethyl)benzyl)-1H-indol-5- yl)pyrimidine-4-carboxamide::US10730866, Compound 112

SMILES C[C@H](Nc1cc(nc(n1)-c1ccc2n(Cc3ccc(cc3)C(F)(F)F)ccc2c1)C(N)=O)C(N)=O

InChI Key InChIKey=LQYAUHIAIPJHMY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 454704   

TargetSodium channel protein type 9 subunit alpha(Human)
Purdue Pharma

US Patent
LigandPNGBDBM454704((S)-6-((1-amino-1-oxopropan-2- yl)amino)-2-(1-(4- ...)
Affinity DataIC50: 4.12E+3nMAssay Description:In vitro assays were performed in a recombinant cell line expressing cDNA encoding the alpha subunit (Nav1.7, SCN9a, PN1, NE) of human Nav1.7 (Access...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2021
Entry Details
US Patent